Sun Pharmaceutical Industries Ltd. closed 13.94% below its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Welcome to the Sun Pharma Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most ...

Nagaraj Shetti of HDFC Securities recommends these two stocks to buy in the short-term - Bajaj Finserv Ltd, and Sun ...

Welcome to the Sun Pharma Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ahead of the market with our in-depth coverage of Sun Pharma, including ...

Following these outcomes, Sun Pharma has decided to discontinue further clinical trials of SCD-044 and has no plans for its ...

Sun Pharmaceutical Industries is discontinuing two trials of its drug candidate SCD-044 for moderate to severe as psoriasis ...

Sun Pharma to invest $100 million in speciality products, targeting growth in innovative treatments for the future.

Sun Pharmaceutical Industries Ltd. closed 14.30% below its 52-week high of 1,960.20 rupees, which the company reached on ...

Sun Pharma's shares experienced a 0.47 per cent decline, trading at Rs 1,659.80, alongside the sharper fall in SPARC shares ...

Despite a healthy performance in the fourth quarter of 2024-25 (Q4FY25), the stock of India's largest listed pharma company, ...

Sun Pharmaceutical Industries, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹1689.45. The stock has experienced fluctuations ...